Bibliografía del artículo
1. Póvoa AA, Teixeira E, Bella-Cueto MR, Melo M, Oliveira MJ, Sobrinho-Simões M, et al. Clinicopathological features as prognostic predictors of poor outcome in papillary thyroid carcinoma. Cancers (Basel). 12(11):3186, 2020.
2. Shih SR, Chang YC, Li HY, Liau JY, Lee CY, Chen CM, Chang TC. Preoperative prediction of papillary thyroid carcinoma prognosis with the assistance of computerized morphometry of cytology samples obtained by fine-needle aspiration: preliminary report. Head Neck 35(1):28-34, 2013.
3. Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al.; ESMO Guidelines Committee. ESMO Clinical Practice Guidelines or diagnosis, treatment and follow-up. Ann Oncol 30(12):1856-1883, 2019.
4. Ferreira RC, Cunha LL, Matos PS, Adam RL, Soares F, Vassallo J, Ward LS. Chromatin changes in papillary thyroid carcinomas may predict patient outcome. Cell Oncol (Dordr) 36(3):259-264, 2013.
5. Lim JXY, Nga ME, Chan DKH, Tan WB, Parameswaran R, Ngiam KY. Subclassification of Bethesda atypical and follicular neoplasm categories according to nuclear and architectural atypia improves discrimination of thyroid malignancy risk. Thyroid 28(4):511-521, 2018.
6. Al-Qurayshi Z, Hauch A, Srivastav S, Aslam R, Friedlander P, Kandil E. A national perspective of the risk, presentation, and outcomes of pediatric thyroid cancer. JAMA Otolaryngol Head Neck Surg 142(5):472-478,2016.
7. Aarestrup J, Kitahara CM, Baker JL. Birthweight and risk of thyroid câncer and its histological types: A large cohort study. Cancer Epidemiol 62:101564, 2019.
8. JNCCN-Journal of the National Comprehensive Cancer Network. Thyroid Carcinoma, Version 2.2018 CE NCCN Guidelines Insights.16(12), 2018.
9. Mungan S, Ersoz S, Saygin I, Sagnak Z, Cobanoglu U. Nuclear morphometric findings in undetermined cytology: A possible clue for prediction of BRAF mutation in papillary thyroid carcinomas. Endocr Res 42(2):138-144, 2017.
10. Li M, Dal Maso L, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol 8(6):468-470, 2020.
11. Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am 48(1):23-35, 2019.
12. Selemetjev SA, Savin SB, Paunovic IR, Tatic SB, Cvejic D. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance. Wien Klin Wochenschr 127(9-10):337-344, 2015.
13. Deeken-Draisey A, Yang GY, Gao J, Alexiev BA. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol 82:140-148, 2018.
14. Cameselle-Teijeiro JM, Bella Cueto MR, Eloy C, Abdulkader I, Amendoeira I, Matías-Guiu X, Sobrinho-Simões M. Tumores de la glándula tiroides. Propuesta para el manejo y estudio de las muestras de pacientes con neoplasias tiroideas. Rev Esp Patol 53(1):27-36, 2020.
15. Rangel-Pozzo A, Sisdelli L, Cordioli MIV, Vaisman F, Caria P, Mai S, Cerutti JM. Genetic landscape of papillary thyroid carcinoma and nuclear architecture: an overview comparing pediatric and adult populations. Cancers (Basel) 12(11):3146, 2020.
16. Basolo F, Macerola E, Ugolini C, Poller DN, Baloch Z. The molecular landscape of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a literature review. Adv Anat Pathol 24(5):252-258, 2017.
17. Eisa N, Khan A, Akhter M, Fensterwald M, Saleem S, Fananapazir G, Campbell MJ. Both ultrasound features and nuclear atypia are associated with malignancy in thyroid nodules with atypia of undetermined significance. Ann Surg Oncol 25(13):3913-3918, 2018.
18. Turk AT, Wenig BM. Thyroid tumors with follicular architecture. Ann Diagn Pathol 38:51- 58, 2019.
19. Castro IV de. Tireoide: a patologia dos núcleos [edi]. Arq Bras Endocrinol Metab 53(7):793-794, 2009.
20. Ferreira RC, Ward LS, Adam RL, Leite NJ, Metze K, Matos PS. Contribuição da análise de textura do núcleo celular para o diagnóstico diferencial de lesões foliculares da tireoide: comparação com marcadores imunoistoquímicos. Arq Bras Endocrinol Metabol 53(7):804-810, 2009.
21. Peres KC, Teodoro L, Pereira Amaral LH, Souza Teixera E, Siqueira Barreto I, Lopes de Freitas LL, et al. Clinical utility of TGFB1 and its receptors (TGFBR1 and TGFBR2) in thyroid nodules: evaluation based on single nucleotide polymorphisms and mRNA analysis. Arch Endocrinol Metab 65(2):172-184, 2021.
21. Nandedkar SS, Dixit M, Malukani K, Varma AV, Gambhir S. Evaluation of thyroid lesions by fine- needle aspiration cytology according to Bethesda system and its histopathological correlation. Int J Appl Basic Med Res 8(2):76-82, 2018.
23. Sinna EA, Ezzat N. Diagnostic accuracy of fine needle aspiration cytology inthyroid lesions. J Egypt Natl Canc Inst 24(2):63-70, 2012.
24. Razavi MA, Wong J, Akkera M, Shalaby M, Shalaby H, Sholl A, et al. Nuclear morphometry in indeterminate thyroid nodules. Gland Surg 9(2):238-244, 2020.
25. Priya SS, Sundaram S. Morphology to morphometry in cytological evaluation of thyroid lesions. J Cytol 28(3):98-102, 2011.
26. Mahfouz SM, El-Sharkawy SL, Sharaf WM, El-din Hussein H, El-Nemr RS. Image cytometry of fine needle aspiration of thyroid epithelial lesions. Appl Immunohistochem Mol Morphol 20(1):25-30, 2012.
27.Yan L, Sethi S, Park JW. Cytologic and clinical features of NIFTP: Can we diagnose based on preoperative fine-needle aspiration. Diagn Cytopathol 47(12):1259-1266, 2019.
28. Hung YP, Barletta JA. A user's guide to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Histopathology 72(1):53-69, 2018.
29. Díaz del Arco C, Fernández Aceñero MJ. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: Can cytology face the challenge of diagnosis in the light of the new classification? Acta Cytol 62(4):265-272, 2018.
30. Maletta F, Falco EC, Gambella A, Metovic J, Papotti M. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: from echography to genetic profile. Tohoku J Exp Med 252(3):209-218, 2020.
31. Chu YH, Sadow PM. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Diagnostic updates and molecular advances. Semin Diagn Pathol 37(5):213-218, 2020.
32. Celik ZE, Altinay S, Kilinc F, Arslan N, Yilmaz BS, Karabagli P, Ugurluoglu C. Using computerized cytomorphometry to distinguish between benign and malignant cases in thyroid fine-needle aspiration cytology. Diagn Cytopathol 44(11):902-911, 2016.
33. Valentim FO, Coelho BP, Miot HA, Hayashi CY, Jaune DTA, Oliveira CC, et al. Follicular thyroid lesions: is there a discriminatory potential in the computerized nuclear analysis? Endocr Connect 7(8):907-913, 2018.
34. Yashaswini R, Suresh TN, Sagayaraj A. Cytological evaluation of thyroid lesions by nuclear morphology and nuclear morphometry. J Cytol 34(4):197-202, 2017.
35. Huang H, Tosun AB, Guo J, Chen C, Wang W, Ozolek JA, Rohde GK. Cancer diagnosis by nuclear morphometry using spatial information. Pattern Recognit Lett 42:115-121, 2014.
36. Cunha LL, Ferreira RC, de Matos PS, da Assumpção LV, Ward LS. Both gender and concurrent chronic lymphocytic thyroiditis may influence the nuclear texture of papillary thyroid carcinomas cells. Endocr Res 39(3):126-129, 2014.
37.Nikonenko AG, Bozhok YM. Simple computational technique to quantify nuclear shape asymmetry. Cytometry A 87(4):309-314, 2015.
38. Deka L, Gupta S, Gupta R, Gupta K, Kaur CJ, Singh SS. Nuclear morphometry and texture analysis on cytological smears of thyroid neoplasms: a study of 50 cases. Malays J Pathol 39(1):33-37, 2017.
39. Mohamed DA, Shamlola MM. Immunohistochemical and morphometrical evaluation of well- differentiated thyroid tumor of uncertain malignant potential. Indian J Pathol Microbiol 62(1):17-23, 2019.
40. Chen CC, Hang JF, Liu CY, Wang YH, Lai CR. Thyroid fine-needle aspiration cytology in Taiwan: a nationwide survey and literature update. J Pathol Transl Med 54(5):361-366, 2020.
41. Coelho BP, Valentim FO, Miot HA, Jaune DTA, Hayashi CY, Oliveira CC, et al. Follicular lesions with papillary nuclear characteristics: differences in chromatin detected by computerized image analysis. Arch Endocrinol Metab 28:S2359-39972020005006205, 2020.
42. Feldkamp J, Führer D, Luster M, Musholt TJ, Spitzweg C, Schott M. Fine needle aspiration in the investigation of thyroid nodules. Dtsch Arztebl Int 113(20):353-359, 2016.
43. Khatri P, Choudhury M, Jain M, Thomas S. Role of morphometry in the cytological differentiation of benign and malignant thyroid lesions. J Cytol 34(1):1-4, 2017.
44. Gilshtein H, Mekel M, Malkin L, Ben-Izhak O, Sabo E. Computerized cytometry and wavelet analysis of follicular lesions for detecting malignancy: A pilot study in thyroid cytology. Surgery 161(1):212-219, 2017.
45. Din?i? M, Todorovi? J, Nešovi? Ostoji? J, Kova?evi? S, Dun?erovi? D, Lopi?i? S, et al. The fractal and GLCM textural parameters of chromatin may be potential biomarkers of papillary thyroid carcinoma in Hashimoto's thyroiditis specimens. Microsc Microanal 26(4):717-730, 2020.
46. Metze K, Adam RL, Ferreira RC. Robust variables in texture analysis. Pathology 42:609-610, 2010